NewAmsterdam Pharma Co N.V. (NAMS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $769.28M | -11.0% |
| 2024 | $864.62M | +149.1% |
| 2023 | $347.10M | -27.5% |
| 2022 | $478.50M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $769.28M | -11.0% |
| 2024 | $864.62M | +149.1% |
| 2023 | $347.10M | -27.5% |
| 2022 | $478.50M | — |